ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,226Medicare Part D Prescriptions Filled, Including Refills

Rank: 280 out of 909

$410K Total Retail Price of All Prescriptions

Rank: 343 out of 909

440 Patients Receiving at Least One Drug in Part D
77% Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Louisiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 440 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

23% of this provider’s 440 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 490 343 99 S3 1 3
SIMVASTATIN 424 366 68 2 6
HYDROCHLOROTHIAZIDE 301 235 45 3 11
LISINOPRIL 284 255 45 4 4
ATENOLOL 278 249 41 5 28
FUROSEMIDE 252 234 49 6 8
MELOXICAM 229 203 42 7 20
OMEPRAZOLE 208 191 38 8 7
POTASSIUM CHLORIDE 205 178 36 9 13
GABAPENTIN 204 165 37 10 12
METFORMIN HCL 178 165 26 11 5
AMLODIPINE BESYLATE 171 126 35 12 1
LEVOTHYROXINE SODIUM 151 134 24 13 2
CITALOPRAM HBR 125 110 18 14 25
ATORVASTATIN CALCIUM 122 117* 17 15 9
WARFARIN SODIUM 122 117* 19 15 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 114* 23 17 24
METOPROLOL TARTRATE 117 104 19 18 16
PANTOPRAZOLE SODIUM 95 70 17 19 27
CLOPIDOGREL 93 88* 15 20 18
ALPRAZOLAM 91 53 19 B 21 14
JANUVIA 85 85 14 22 58
DONEPEZIL HCL 85 80* 15 22 37
NEXIUM 85 80* 16 22 17
CARVEDILOL 83 69 12 25 21
TRAMADOL HCL 82 59 28 26 15
LOSARTAN-HYDROCHLOROTHIAZIDE 78 63 12 27 52
LANTUS 73 68* 18 28 59
DIVALPROEX SODIUM 72 <11 <11 29 111
ESCITALOPRAM OXALATE 71 <11 <11 30 36
LOSARTAN POTASSIUM 67 62* 12 31 23
CLONIDINE HCL 66 <11 <11 32 39
SERTRALINE HCL 65 53 13 33 30
NOVOLIN R 64 59* 11 34 159
TAMSULOSIN HCL 62 49 13 35 33
METOPROLOL SUCCINATE 59 <11 <11 36 19
CLONAZEPAM 58 40 13 B 37 42
HYDROXYZINE HCL 57 43 17 R 38 213
NIFEDIPINE ER 54 <11 <11 39 76
ALLOPURINOL 54 <11 <11 39 35
ISOSORBIDE MONONITRATE ER 53 <11 <11 41 65
RISPERIDONE 52 <11 <11 A 42 85
MUPIROCIN* 51 33 20 43 120
CARISOPRODOL 50 31 15 R 44 79
MONTELUKAST SODIUM 50 37 12 44 43
POLYETHYLENE GLYCOL 3350 50 45* 13 44 71
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.